check_circleStudy Completed

Relapsing-Remitting Multiple Sclerosis

Injection management with Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)

Trial purpose

Aim of the BETAPATH study is to evaluate whether the use of a personal digital assistant (PDA) can improve the adherence of Multiple Sclerosis patients to a therapy with Betaseron. The Personal digital assistant PDA functions as an electronic diary and as an injection reminder.

Key Participants Requirements

Sex

Both

Age

18 - N/A

Trial summary

Enrollment Goal
702
Trial Dates
May 2009 - August 2014
Phase
N/A
Could I Receive a placebo
No
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, Germany

Primary Outcome

  • Drop out rate over 2 years
    date_rangeTime Frame:
    24 months
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • Disability status
    date_rangeTime Frame:
    After 3, 6, 12 and 24 months
    enhanced_encryption
    Safety Issue:
    No
  • Grade of depressiveness
    date_rangeTime Frame:
    After 3, 6, 12 and 24 months
    enhanced_encryption
    Safety Issue:
    No
  • Grade of fatigue
    date_rangeTime Frame:
    After 3, 6, 12 and 24 months
    enhanced_encryption
    Safety Issue:
    No
  • Quality of life
    date_rangeTime Frame:
    After 3, 6, 12 and 24 months
    enhanced_encryption
    Safety Issue:
    No
  • Cognitive status
    date_rangeTime Frame:
    After 12 and 24 months
    enhanced_encryption
    Safety Issue:
    No
  • Injection regularity
    date_rangeTime Frame:
    After 3, 6, 12 and 24 months
    enhanced_encryption
    Safety Issue:
    No

Trial design

Betaferon® injection management: Non-interventional study on personal digital assistant (PDA)supported effects on Adherence to a long-term injection Therapy (BETAPATH)
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A